, which reported the finding of a biphasic or biexponential DTPA clearance curve and its use in the management of patients with HIV infection and pneumocystis pneumonia. We have found the test sensitive and useful.'2 There are, however, some issues raised by the method used that are worth exploring. The most crucial point is the lack of separation of the patients with pneumocystis pneumonia and those that are smokers without pneumocystis pneumonia. This observation makes the suggestion that an analysis of the first seven minutes of data acquisition is sufficiently reliable to separate those with pneumocystis pneumonia from others who smoke unlikely. The methods of data acquisition and processing described might explain the insensitivity of the method. There are several problems.
Firstly, the patients inhale aerosol for four minutes, and yet the halftime ofthe clearance reported by others is between one and five minutes1'; it is therefore likely that the initial fast component is at least partially obscured with this inhalation time.
Secondly, the aerosol inhalation was performed in the erect posture, which would result in reduced counts over the upper lobes (which also have faster transfer times than the lower). This would be a particular problem in sick patients who cannot remain still. Possibly this led to the reduced sensitivity in the measurements over the upper part of the lung.
Thirdly, the background radiactivity varies between the apex of the lung and the base45 and in the paper by Langford et al was found to vary in non-smokers. 6 AUTHOR'S REPLY The aim of our paper was to examine the suggestion that DTPA lung clearance might be a useful method of investigating HIV seropositive patients with respiratory symptoms. The future role of this investigation will depend on wider experience, from its application in different centres. We note with interest the comments on methodological points. As we mentioned in our discussion, the main difference between our method and that used by O'Doherty and others stemmed from the faster flow rate they used and therefore presumably the smaller particle size. Possibly this would have a greater discriminatory value and, as we have said, we believe that this is an area for further investigation, though each centre is likely to have its own method until consensus is achieved. The seven minute clearance times for smokers did give significant separation in our study between those with and without pneumocystis pneumonia. Although differences were not as pronounced as for nonsmokers, the important point was our finding that resolution did not appear to be improved by a longer scan time. We analysed upper and lower lung zones separately and did not find any difference between the two in discriminatory power for pneumocystis pneumonia; thus we did not detect any greater variability in upper than in lower lung zones. We would agree that sick patients might not tolerate the scan (in either erect or any other posture) but we think that DTPA scanning may not be an appropriate investigation in such patients. We have examined the effect of intravenous injection to determine background in some of our patients and this does not appear to improve our protocol significantly. DOUGLAS 
